NEWSpublisher 2007 :: AngloChinese Investments
SEARCH NEWS
date from:
date to:
company:
search for string:
NEWS SECTIONS
COMPANY GROUPS
TOP NEWS
» 23/07/2009 [Company watch]
China Aoxing Pharmaceutical Corp. Receives Renewal of GMP Certification for Capsule Dosage Form of Pharmaceutical Products
» 15/03/2010 [Industry news]
Recordati S.p.A And Lee Pharmaceutical Announce Partnership For Zanidip(R) In China
» 26/10/2009 [Finance]
China Growth to Remain Fast in Fourth Quarter, Official Says
» 17/08/2009 [Industry news]
Chindex Posts Profit on Product Sales, Health Services
» 07/05/2010 [Industry news]
Hong Kong: Recall of all products manufactured by Quality Pharmaceutical Lab Ltd
COMPANY NEWS » Industry news » Contract Research Orgs  1    
found files: 12
NCCSED »06/03/2007 [Industry news]
Frontier links with NCCSED (CRO) in China

US based Frontier Biosciences has signed agreement with National Chengdu Centre for Safety Evaluation of Drugs - a full service pre-clinical CRO regarded as one of the best in China - established by West China Hospital of the Sichuan University...   more»


Wuxi Pharma Tech »07/04/2007 [Industry news]
WuXi PharmaTech Sets Up Life Science and Chemistry Award

WuXi PharmaTech, China's leading provider of pharmaceutical outsourcing services is pleased to announce the establishment of the "WuXi PharmaTech Life Science and Chemistry Award"; worth one million RMB. The award will honor individuals and groups who make a significant contribution to the fields of life science and chemistry in China....   more»


Excel PharmaStudies Inc. »28/11/2008 [Industry news]
Rural Population Key to China’s Clinical Research Market

In his presentation at China Trials 2008 in Shanghai, Mark Engel, president and chairman of Excel PharmaStudies, a large China-based contract research organization, identified two megatrends that will drive post-marketing surveillance studies to China: the rapid aging of its population and its increasingly insured rural population....   more»


TOP NEWS
Wuxi Pharma Tech
»23/06/2009 [Industry news]
WuXi AppTec appoints new senior vice president with device industry pedigree

Hsu will be primarily responsible for WuXi US business....   more»


Sundia MediTech Company,Ltd. »28/06/2009 [Industry news]
Sundia and 2 Other CRO Companies Granted Express Customs Clearance Privilege in Shanghai

Shanghai Pudong Customs, Pudong International Airport Customs and Zhangjiang Group Co. held ceremony in the Zhangjiang Hi-Tech Park to initiate the Express Customs Clearance for 3 biopharmaceutical R&D outsourcing (CRO) companies....   more»


Sundia MediTech Company,Ltd. »06/07/2009 [Industry news]
Dr Chen joins Sundia chemistry services team

Sundia MediTech, an integrated pharmaceutical and biotech R&D outsourcing company in Shanghai, China, has appointed Dr Chen Chen as the Senior Vice President of Chemistry Services....   more»


VENTURE PHARM SERVICE--VPScro »05/08/2009 [Industry news]
AlphaRx, Venturepharm announce collaboration agreement

The goal of this is to enhance AlphaRxs research capabilities, expedite the development of new products as well as to expand the its product range....   more»


TOP NEWS
Sundia MediTech Company,Ltd.
»01/09/2009 [Industry news]
Sundia gets the (Highest Growth Potential) award

Sundia MediTech, a pharmaceutical R&D outsourcing company in China, has received the Highest Growth Potential Award from Zhangjiang Hi-Tech Park on August 26....   more»


TOP NEWS
Wuxi Pharma Tech
»23/10/2009 [Industry news]
WuXi PharmaTech appoints Dr Hui Cai as VP of Business Development

Dr Hui Cai has been appointed as Vice President of Business Development. She will report directly to Dr Richard M. Soll, Senior Vice President of Integrated Services....   more»


TOP NEWS
Bridge (Vital Bridge)
»11/01/2010 [Industry news]
Pharmaron LLC Expands Portfolio of Services with Acquisition of Bridge Laboratories China

Pharmaron Holdings Limited, today announced it completed the acquisition of Bridge Laboratories China....   more»


TOP NEWS
Wuxi Pharma Tech
»26/02/2010 [Industry news]
WuXi Pharma COO Highlights Planned Growth

WuXi PharmaTech plans to continue its growth by expanding into biotech, safety evaluation and manufacturing. In fact, to make the growth a reality, the company invests about $60 million each year in capital expenditures....   more»


TOP NEWS
Wuxi Pharma Tech
»23/02/2010 [Industry news]
WuXi toxicology facility gets AAALAC accreditation

Wuxi Pharmatech said that its Suzhou non-clinical safety testing facility received full accreditation from the Association for the Assessment and Accreditation of Laboratory Animal Care International (AAALAC)....   more»

AngloChinese Investments ltd.
Home | Company news | TOP 50 | Events | About us
C&F Bright Solutions ltd.